Do Cardiac Health: Advanced New Generation Ecosystem - Phase 2

NCT03178305 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2018-07-26

No results posted yet for this study

Summary

The Do CHANGE service is designed for cardiac patients who could benefit from lifestyle change and a better disease management. The study aims to support patients with behavior change by providing them with devices and behavioral intervention in order to facilitate long-term behavior change.

Conditions

Interventions

BEHAVIORAL

Do CHANGE

Besides the behavior change programme (Do Something Different) 1. All patients will receive: Fitbit, Beddit, Care-portal, Do CHANGE app (including dietary habits picture taking), CookiT (smart spatula that monitors cooking behavior) 2. patients with heart failure will, in addition to the above mentioned, be offered a weight scale, blood pressure monitor, and FluiT (smart cup to measure fluid intake). 3. Patients with hypertension will also be offered a bloodpressure monitor. Data from these devices will be gathered and visible for patients (in patient portal) and for their health care provider (health care provider portal). In case of negative results the patient will be contacted by their health care provider (usually the cardiologist). Once every week the patients will be contacted to discuss their progress and will be given feedback about their dietary intake.

Sponsors & Collaborators

  • European Commission

    collaborator OTHER
  • Badalona Serveis Assistencials

    collaborator OTHER
  • Smart Homes

    collaborator UNKNOWN
  • ONMI

    collaborator UNKNOWN
  • Eindhoven University of Technology

    collaborator OTHER
  • Docobo Ltd.

    collaborator INDUSTRY
  • Do Something Different

    collaborator OTHER
  • Buddhist Tzu Chi General Hospital

    collaborator OTHER
  • The Industrial Technology Research Institute

    collaborator OTHER
  • Elisabeth-TweeSteden Ziekenhuis

    lead OTHER

Principal Investigators

  • Jos Widdershoven, MD, PhD · Elisabeth-TweeSteden Ziekenhuis

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-27
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • Spain
  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03178305 on ClinicalTrials.gov